Pfizer

•

Channel • 7 Shows

Life Sciences

Life Sciences

Updated Weekly
Science Fiction

Science Fiction

Series
Life Sciences

Life Sciences

Updated 21/11/2023
Life Sciences

Life Sciences

Updated Monthly
Medicine

Medicine

Updated 17/09/2025
Medicine

Medicine

Updated Weekly
Life Sciences

Life Sciences

Updated 15/12/2025

4 DAYS AGO

Living Longer with Cancer: Rethinking Survivorship

What comes after a cancer diagnosis and treatment? In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most important, and often overlooked, chapters for cancer patients: survivorship. As five-year survival rates climb to 70%, more people than ever are living with and beyond cancer. But longer survival brings its own complex challenges, and our care systems are still catching up. You'll hear from experts and advocates working at the intersection of medicine, policy, and community. We’ll discuss what it really takes to support people through this transition — when the clinical benchmarks have passed and it’s time to go back to “normal life”. From patient care plans and workplace disclosure to mental health, this episode makes one thing clear: survivorship demands dignity, support, and a whole new kind of care. Featured guests: – Tina Deignan, Commercial President, Pfizer Oncology – Shelley Fuld Nasso, CEO, Cancer Nation – Rebecca Nellis, Executive Director, Cancer and Careers – Bob Riter, Breast Cancer Patient & Advocate Dive into the episode here: 00:00 – The ongoing battle with cancer 03:43 – Rethinking survivorship 05:32 – The five-year survival myth 07:00 – The history of the term "survivor" 09:36 – Bob’s journey with breast cancer 11:38 – Lost in transition and survivorship care plans 14:25 – The intersection of cancer and work 18:49 – Rethinking how work gets done 20:00 – Disclosure and improving company culture 20:59 – The swivel technique 23:19 – Controlling your narrative 25:11 – Standardizing long-term survivorship care through policy 27:08 – Lack of access to care leads to disparities in survival rates 29:48 – Bob's second journey with cancer 32:21 – Takeaways and peek into our final episode Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Bob Riter on his cancer journey. Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4 days ago

•

34 min
18/04/2024 · BONUS

Live from SXSW - Moonshot Culture: Innovating to Outdo Yesterday

Throughout history, humans have coalesced around moonshot culture to achieve audacious goals—from eradicating smallpox, to sequencing the human genome, to landing a spacecraft on Mars. These feats of human ingenuity didn’t happen in a vacuum, they were born from intentional innovation, a “coalition of the willing,” and a vision to outdo yesterday. This fireside chat with Drew Panayiotou, Former CMO of Pfizer and Devon Still, ex-NFL player and founder of Still Strong Foundation, explores innovations in cancer, their personal experiences with family members needing healthcare treatment, and what it will take to achieve Pfizer's next big moonshot to outdo cancer and achieve its vision, a world where people with cancer live better and longer lives. This episode was recorded live in Austin, TX on Monday March 11 as part of Pfizer’s takeover of the South by Southwest podcasting lounge. The Let's Outdo Cancer Campaign aims to focus on advances in fighting against cancer. To learn more, visit letsoutdocancer.com. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

18/04/2024 · Bonus

•

50 min
04/03/2025

Part 4 – New Frontiers in AI & Drug Discovery

So far in this season, we’ve explored how innovations throughout history have brought us to where we are now. We talked about how drug discovery changed from a serendipity-based to data-based endeavor. Then, we explored the powerful hardware and smart software required to accommodate big data. Now, the door to the future of AI in drug discovery is open. In our final episode, we’re looking toward the future, to understand where today’s advancements could potentially take us. Featured Guests: –Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer –Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer –Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer –Dr. Raza Ali, group leader at the University of Cambridge Cancer Research UK Institute, pathologist Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

04/03/2025

•

24 min
18/04/2024 · BONUS

Live from SXSW - Scientific Storytelling: The Audio Advantage

Podcasting has exploded in the last 5 years, with every celebrity, brand, and influencer investing in audio. It’s estimated that 144MM people in the U.S. listen to a podcast monthly. With scale and an ability to build audience connections, podcasts have become effective at communicating complex information in a digestible way–making them perfect for sharing science-based stories. Many have heard the term "gene therapy," but how many know what it means? How do you explain the science behind artificial intelligence or designing the Mars Rover? Audio allows us to do this, while enhancing the impact of science communications. Join the Pfizer Podcast team, NASA, UT Austin, and Wonder Media Network as they share their audio expertise and accessible approach to scientific storytelling. Featured experts: Shira Atkins, CRO & Co-Founder, Wonder Media NetworkEllen Gerstein, Head Of Digital Communications, Pfizer Inc.Katie Konans, Audio Storytelling Lead, NASAKristen Wynn, Program Manager, The University of Texas at Austin, Dell Medical School, Livestrong Cancer InstitutesThis episode was recorded live in Austin, TX on Monday March 11 as part of Pfizer’s takeover of the South by Southwest podcasting lounge. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

18/04/2024 · Bonus

•

52 min
18/04/2024 · BONUS

Live from SXSW - The Future of Cancer

In a live taping of the Science Will Win podcast, Host and Artificial Intelligence Expert Jeremiah Owyang speaks to cutting-edge healthcare leaders about the impact that AI is having on the future of cancer. Thirty years ago, the thought of a world without cancer was nothing more than a dream. Similarly, AI was considered a technology that had yet to become reality. Today, we are reimagining a future where the AI revolution will help change the trajectory of cancer as we know it. Featured experts: Edward Cox, Head & General Manager Of Digital Health & Medicines, PfizerJulie Gerberding, CEO and President, Foundation for the National Institutes of HealthMaimah Karmo, Founder & CEO, Tigerlily FoundationThis episode was recorded live in Austin, TX on Monday March 11 as part of Pfizer’s takeover of the South by Southwest podcasting lounge. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

18/04/2024 · Bonus

•

44 min
19 FEB

The Alarming Rise of Early-Onset Cancers

Why are more young adults getting cancer? That's one of the most pressing questions facing the scientific community today. Traditionally thought of as a disease that affects aging populations, recent data shows that cancer diagnoses for people under the age of 50 are increasing. To tackle this problem, it’ll take a global effort. In this episode you’ll hear from patients, oncologists, researchers and health care providers who are coming together to address this issue head on. Featured guests: – Dr. Marshall Anthony Jr., social scientist and colorectal cancer patient – Dr. Johanna Bendell, Chief Development Officer of Oncology, Pfizer – Dr. Yin Cao, molecular cancer epidemiologist; Cao Lab leader, Washington University – Dr. Beatrice Dionigi, colorectal cancer surgeon; founder & co‑director, Early Onset Colon and Rectal Cancer Project, Columbia Research Cancer Center – Dr. Susan Zhang, Global Development Lead, Pfizer Oncology Dive into the episode here: 00:00 – A patient story reveals an alarming new trend 6:30 – The data behind the rise of early-onset cancer 10:39 – The global search for a cause 14:13 – The unique challenges facing young people with cancer 20:28 – Screening guidelines and what to expect from a colonoscopy 25:17 – The importance of early detection 27:59 – The conclusion of Marshall's cancer journey 30:23 – What's next, and closing thoughts Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Dr. Marshall Anthony Jr. on his colorectal cancer journey. Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

19 Feb

•

34 min
26 FEB

Bringing Cancer Into Focus: Biomarkers & Precision Medicine

What if the key to treating cancer was hiding in plain sight – written into its DNA? In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most exciting breakthroughs in cancer care today: the discovery of biomarkers. These tiny molecular signals are helping doctors understand what’s really driving an individual person’s cancer – and opening the door to treatments that can dramatically change patient outcomes. You’ll hear powerful stories from people whose cancers were traced back to a specific biomarker, alongside experts who break down what biomarker testing is, how it works, and why it’s transforming the way we think about cancer treatment. Biomarkers are showing us that when we understand cancer at its molecular level, a disease that once felt like an unsolvable mystery starts to come into focus. Featured guests: – Dr. Ross Camidge, Director of Thoracic Oncology, University of Colorado – Kelly Huffman, Lung Cancer Patient and Retail Account Manager, Pfizer – Karin Tollefson, Chief Oncology Medical Officer, Pfizer Dive into the episode here: 00:00 – An oncologist’s diagnosis introduces the world of biomarker 03:10 – Defining biomarkers and its history 06:24 – Discovery of the first lung cancer biomarker 08:39 – The start Kelly’s lung cancer journey 16:00 – Biomarkers: how do you test for them? 19:11– Discovery of ALK biomarker shift’s Kelly’s story 22:34 – Landscape of targeted therapy and lung cancer today 25:24 – Moving forward with targeted treatments and conclusion Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Kelly Huffman on her lung cancer journey. Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

26 Feb

•

30 min
05/12/2023

Part 4 – Using AI to Get One Step Ahead of Antibiotic Resistance

Is it possible to live in a world without antibiotic resistant bacteria? For the final episode of this season, we’re looking ahead to the future and getting a glimpse of a potential world in which we stay one step ahead of AMR, and what is helping us get there. Host Jeremiah Owyang and expert guests will talk about the education, surveillance, and policy efforts needed for success in the fight against antibiotic resistant bacteria. And we’ll explore how artificial intelligence can empower us in those efforts — and enable more effective, accessible, and equitable healthcare. Featured Guests: Dame Sally Davies, UK Special Envoy for Antimicrobial ResistanceDaniel Gallego, President of the European Kidney Patient FederationRanjit Kumble, Vice President of Enterprise Data Science and Advanced Analytics, PfizerSubha Madhavan, Vice President & Head of AI/ML, Quantitative & Digital Sciences, Global Biometrics & Data ManagementJay Purdy, Vice President and Therapeutic Area Lead, Global Medical Affairs, Pfizer Antibacterial and Antifungal Programs Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

05/12/2023

•

32 min
04/11/2025

Part 2 — The Mighty, Multifaceted Molecule

The next frontier of medicine is focused on highly targeted drug therapies that could expand the possibilities of individualized patient care. Today, scientists are working on a particular type of molecule that could harness multiple capabilities and treat inflammatory and autoimmune diseases in ways never done before. In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how the latest advancements in antibody engineering led to multispecific antibodies—powerhouse molecules that can do the jobs of multiple drugs in one. They learn all about what it takes to assemble these antibodies and the impact they could make on patients—with a patient. Featured Guests: – Emma Guttman, Chair of the Department of Dermatology, Icahn School of Medicine at Mount Sinai – Amanda Lopez, Patient, Texas Ambassador for the National Eczema Association – Laird Bloom, Senior Director of Biomedicine Design, Pfizer – Thomas Wynn, Vice President of Discovery, Inflammation & Immunology, Pfizer Dive into the episode here: 1:12 - A metaphor for multispecific antibodies 4:08 - How do multispecific antibodies work? 10:39 - The history behind multispecific antibodies 16:29 - How are multispecific antibody drugs are made? 22:58 - An eczema expert on the potential of multispecific antibodies 29:30 - Amanda Lopez's eczema story 40:14 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

04/11/2025

•

42 min
28/10/2025

Part 1 — The Case of the Missing Vaccine

Medical advancements don’t just spring up—they happen by building on decades of previous discoveries. Today, one of these advancements might be on the verge of another breakthrough. But what had to happen first for it to exist? In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how a vaccine candidate for a deadly, once-mysterious bacterial disease came to be. The story takes them from one doctor’s groundbreaking connection in the 70s, all the way to a real lab where vaccines are being developed today. Featured Guests: – Carol Baker, Pediatric Infectious Disease Specialist – Isis Kanevsky, Senior Director, Vaccines, Pfizer – Ksenia Krylova, Senior Director, Vaccines, Pfizer Dive into the episode here: 02:54 - Getting into the problem 05:11 - The basics of immunity and vaccine science 09:32 - What is a conjugate vaccine? 14:44 - Group B Strep: A case study 22:23 - Talking to a GBS pioneer 31:40 - A trip to the lab 43:08 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

28/10/2025

•

49 min

Go behind the breakthroughs and explore the stories of the work we do at Pfizer around the globe, in conversations with the scientists and leaders who make it happen. Listen to recent episodes and follow along.

Website

Pfizer

Top Shows

Top Episodes

About